# LLM call: summary

- Turn: 5
- Sequence: 8
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 707
- Completion tokens: 340
- Total tokens: 1160
- Cost (USD): 0.00014

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1286: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
First-half 2028 studies showed assistants lifted white-collar output, especially for juniors, without cutting headcount — relief for jobs, repricing for investors as automation hopes faded. Venture stayed cold, cancelled hyperscale builds stayed cancelled, leaving InvestAI's distressed salvage of sites/grid reservations as the sovereignty bet.

That bet froze: coordinated municipal protest and court injunctions on power/water connections halted installation at one salvaged site for months. Brussels responded with linkage — seeking a transatlantic side-letter for quota relief/fast end-use clearance for verified labs/hospitals in exchange for screening/evaluation uptake, and a Competitiveness Council template benefit package (water standards, community payments, phased grid) with regional adjudication. Neither delivered in-turn: Washington kept volume licences with no fast lane; injunction held during mediation; deliveries slipped again and Gigafactory completion stayed unchanged despite priority status.

Partial wins: harm-reporting desk expanded with falling waiting/decision times where used, softening benefits-fraud discrimination fallout; segmented Shield operators again rode through probes; biosecurity refits hit milestones amid cost warnings.

CURRENT NARRATIVE:
### The signal and the site
Autumn 2028 brought two different kinds of news to Brussels. In closed biosecurity channels, a genome model study claimed a non-expert with assistance could reach a viable human-infecting design. Methodologists quarrelled, editors hesitated, but health officials read it as categorically new. Publicly, the fight was concrete and muddy: around the salvaged hyperscale site, the municipal moratorium held, and a court kept power and water injunctions in place while mediation ran. Engineers guarded empty pads; deliveries slipped a quarter.

The Union closed its two-year commitment period straddling both. The screening refits ordered two years earlier finished — hospital and lab upgrades signed off — while a new surge started through HERA and the disease control centre: wastewater and clinical sequencing in shield-covered regions, triage exercises in refit hospitals, joint procurement of countermeasure inputs.

Washington added a third element. In November, Americans elected a president promising coalition over fortress: structured allied access on published terms, joint evaluation and incident reporting, relaxed tiering for partners in exchange for alignment on export controls and standards. Relief in Brussels was immediate; trade officials kept the volume-licence channel alive without conceding alignment before inauguration.

Nothing unfroze in-turn. The Competitiveness Council benefit template — water-efficiency, community payments, phased grid — went into court-supervised mediation with the host region, holding unfrozen sites and grid reservations but lifting nothing. The transatlantic side-letter again produced no fast lane. The Gigafactories' finishing date was again left unchanged despite priority status, a fact host-region papers noted.

Smaller cushions held. The harm-reporting desk expanded, waiting times fell where used, and segmented grid operators rode through autumn probes. That, plus the finished refits, kept the contested biology paper inside expert circles rather than on front pages.
```

## Raw response

```
First-half 2028 productivity studies and cold venture left InvestAI's distressed salvage of hyperscale sites as the sovereignty bet, but municipal moratorium and court injunctions on power/water kept the salvaged site frozen with slipping deliveries and unchanged Gigafactory completion.

Autumn 2028 added biosecurity alarm: a genome-model study claimed AI-assisted non-experts could reach viable human-infecting designs, read by health officials as categorically new despite methodological dispute. In response the Union closed its two-year commitment: ordered screening refits for hospitals/labs finished and signed off, while HERA/ECDC launched a new surge — wastewater/clinical sequencing in shield regions, triage exercises, joint countermeasure procurement.

Washington shifted with November election of a coalition-oriented president promising structured allied access, joint evaluation/incident reporting and relaxed tiering for export-control alignment; Brussels kept volume licences alive without pre-inauguration concessions. Neither Brussels track unfroze in-turn: Competitiveness Council benefit template went into court-supervised mediation holding but not lifting sites/grid, transatlantic side-letter again yielded no fast lane. Harm-reporting desk expansion with falling waits and resilient segmented grid operators contained fallout and kept the biology paper out of front pages.
```
